The report on the Global Genome Editing Market gives an estimation of the development of the market based on historical studies and also provides forecasts on the basis of comprehensive research. The report gives a complete market analysis for the forecasted period from 2020 to 2026. The market is divided into various segments with an in-depth outlook of the competitors and a listing of the profiled key players. The market size in terms of revenue (USD MN) is calculated and provided for the study period along with the dynamics of the market such as the drivers and the restraints.
Drivers
- Growing demand for synthetic genes and genetically modified organisms
- Rising adoption of technological advancements in gene editing technologies
- Rising adoption in agricultural biotechnology
Restraints
- IP disputes related to CRISPR technology amongst the industry players
Furthermore, the report quantifies the market share held by the major players of the industry and provides an in-depth view of the competitive landscape. This market is classified into different segments with detailed analysis of each with respect to geography.
The comprehensive value chain analysis of the market will assist in attaining better product differentiation, along with detailed understanding of the core competency of each activity involved. The market attractiveness analysis provided in the report aptly measures the potential value of the market providing business strategists with the latest growth opportunities.
The report classifies the market into different segments based on Technology, Delivery Method, application and Service. These segments are studied in detail incorporating the market estimates and forecasts at regional and country level. The segment analysis is useful in understanding the growth areas and probable opportunities of the market.
The report also covers the complete competitive landscape of the worldwide market with company profiles of key players such as:
- AstraZeneca
- Caribou Biosciences, Inc
- Cellectis
- Cibus
- CRISPR THERAPEUTICS
- Editas Medicine
- Egenesis Inc.
- Horizon Discovery Group plc
- Integrated DNA Technologies, Inc.
- Intellia Therapeutics, Inc.
- Merck KGaA
- Precision Biosciences
- Recombinetics, Inc
- Sangamo
- Takara Bio USA
A detailed description of each has been included, with information in terms of H.Q, future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other latest industrial developments.
SEGMENTATIONS IN THE REPORT:
By Technology Outlook:
- (CRISPR)/Cas9
- TALENs/MegaTALs
- ZFN
- Others
By Delivery Method:
By Applications:
- Cell Line Engineering
- Animal Genetic Engineering
- Plant Genetic Engineering
- Other Applications
By Service:
By Geography:
- North America (NA) – US, Canada & Rest of North America
- Europe (EU) – UK, Germany, France & Rest of Europe
- Asia Pacific (APAC) – China, Japan, India & Rest of APAC
- Latin America (LA) – Brazil & Rest of Latin America
- Middle East & Africa (MEA) – Middle East and Africa
The Global Genome Editing Market has been exhibited in detail in the following chapters -
Chapter 1 Genome Editing Market Preface
Chapter 2 Executive Summary
Chapter 3 Genome Editing Industry Analysis
Chapter 4 Genome Editing Market Value Chain Analysis
Chapter 5 Genome Editing Market Analysis By Technology Outlook
Chapter 6 Genome Editing Market Analysis By Delivery Method
Chapter 7 Genome Editing Market Analysis By Applications
Chapter 8 Genome Editing Market Analysis By Service
Chapter 9 Genome Editing Market Analysis By Geography
Chapter 10 Competitive Landscape Of Genome Editing Companies
Chapter 11 Company Profiles Of Genome Editing Industry